Pfizer and Shire last month were dragged into an ongoing patent-infringement lawsuit filed by Isis Pharmaceuticals against Santaris Pharma, with Isis asking for a court order to force the two drug makers to provide information it claims is relevant to the legal proceedings.

In court filings obtained by Gene Silencing News, Isis alleged that Pfizer and Shire, which partnered with Santaris to develop locked nucleic acid-based therapeutics, have neglected to provide subpoenaed documents in a timely manner.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.